Skip to main content

SeaStar Medical Holding Corp

ICUCW
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001831868

In the last 90 days, SeaStar Medical Holding Corp insiders filed 2 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q3 2026, worth $16.6K in total; no superinvestor holds it.

Other share classesICU

Key figures

Market capClose on Nov 18, 2026
$5.53M
Insider buysLast 90 days, $8.71K in total
2
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, −1 vs. previous quarter
13
13F valueReported value at the end of Q3 2026
$16.6K
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$1.23M
+814.1% year over year
Net income, FY2025
-$12.2M
No comparable prior period
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q3 FY2026
$635.0K
+247.0% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $12.2M (984.6% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
1.76K
Shares sold short
Change
−74
−4.0% vs. previous
Days to cover
1.00
At average daily volume

Superinvestors holding ICUCW, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding ICUCW at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by SeaStar Medical Holding Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2026 (view filing)6:13 PM ETNov 161 dayMessinger MichaelChief Financial OfficerPPurchaseCommon Stock, par value $0.0001+2.50K$0.8498+$2.12K+100.0%5.00K after
Nov 17, 2026 (view filing)6:13 PM ETNov 161 dayChung KevinChief Medical OfficerPPurchaseCommon Stock, par value $0.0001+7.80K$0.8448+$6.59K+27.8%35.8K after
Aug 19, 2026 (view filing)4:21 PM ETAug 181 dayMessinger MichaelChief Financial OfficerPPurchaseCommon Stock, par value $0.0001+750$3.27+$2.45K+42.9%2.50K after
Dec 22, 2025 (view filing)6:55 PM ETDec 193 daysBaird Jennifer ADirectorPPurchase+4.20K$0.2351+$987.42+13.1%36.2K after
Dec 11, 2025 (view filing)6:49 PM ETDec 92 daysMessinger MichaelChief Financial OfficerPPurchase+14.5K$0.3516+$5.10K+483.3%17.5K after
Aug 28, 2025 (view filing)Aug 26-272 daysVan Heel KennethDirectorPPurchaseCommon Stock, par value $0.0001 per share+35.0K$0.8814+$30.9K+243.1%49.4K after2 lots
Aug 25, 2025 (view filing)Aug 223 daysChung KevinChief Medical OfficerPPurchaseCommon Stock, par value $0.0001 per share+10.0K$0.80+$8.00K+20.8%58.2K after
Jul 2, 2025 (view filing)7:32 PM ETJun 302 daysBaird Jennifer ADirectorPPurchaseCommon Stock, par value $0.0001 per share+10.0K$0.4174+$4.17K+55.6%28.0K after
Jun 27, 2025 (view filing)6:00 AM ETJun 243 daysLateNeuman JohnDirectorPPurchaseCommon Stock, par value $0.0001 per share+40.0K$0.3599+$14.4K+100.0%80.0K after
May 22, 2025 (view filing)May 202 daysBaird Jennifer ADirectorPPurchaseCommon Stock, par value $0.0001 per share+10.0K$1.28+$12.8KNew position10.0K after

Top 10 13F holders, Q3 2026

See all 13 holders

The largest institutional positions in SeaStar Medical Holding Corp at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding ICUCW in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Boothbay Fund Management, LLC245,200$4.00K0.00%00.0%Unchanged
Linden Advisors LP218,073$3.62K0.00%00.0%Unchanged
Goldman Sachs Group Inc139,032$2.27K0.00%−72,349−34.2%Reduced
LMR Partners LLP125,000$2.04K0.00%00.0%Unchanged
Susquehanna International Group, LLP91,432$1.49K0.00%+55,253+152.7%Added
Clear Street Group Inc.46,690$7610.00%00.0%Unchanged
Tenor Capital Management Co., L.P.40,000$6520.00%00.0%Unchanged
Equitec Proprietary Markets, LLC35,700$5820.00%00.0%Unchanged
Cruiser Capital Advisors, LLC32,473$5290.00%00.0%Unchanged
Two Sigma Securities, LLC21,813$3560.00%−2,509−10.3%Reduced